Rescue of glutaric aciduria type I by GalNAc-conjugated siRNA against aminoadipate semialdehyde synthase
Science Translational Medicine · 18.11.2026 · 18 (876)
DOI: 10.1126/scitranslmed.aej2067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 18.11.2026. Verfasst von Yunhan Ma und 14 weiteren Autor:innen. Beteiligte Einrichtung: Alice and Y. T. Chen Center for Genetics and Genomics, Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham…. Hauptthemen laut MEDLINE: RNA, Small Interfering, Amino Acid Metabolism, Inborn Errors, Brain Diseases, Metabolic, Acetylgalactosamine. Die Arbeit nennt 18 Literaturangaben. Gefördert von: National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, Alnylam Pharmaceuticals.
Abstract (Originalsprache)
Glutaric aciduria type I (GA-1) is a severe metabolic disorder caused by a deficiency of glutaryl-CoA dehydrogenase (GCDH), leading to accumulation of organic acids in the brain and resulting in striatal injury and progressive movement disorders. Although early diagnosis and dietary management reduce risk, one-third of patients still develop debilitating neurological complications. We previously demonstrated that liver-specific deletion of aminoadipate semialdehyde synthase (AASS), an upstream enzyme in lysine degradation, is a promising therapeutic strategy. Here, we tested an N -acetylgalactosamine (GalNAc)–conjugated siRNA against Aass . Treatment of neonatal Gcdh −/− mice rescued lethality and improved the brain pathology while reducing toxic metabolites in the brain and other organs. Serum biomarkers, including glutaric acid, 3-hydroxyglutaric acid, and glutarylcarnitine, predicted neurological outcomes, supporting their use for therapeutic monitoring. Although systemic metabolite concentrations declined, their urinary excretion remained elevated, consistent with a renal washout phenomenon and preserved excretory capacity. These findings demonstrate the potential of liver-targeted small interfering RNA (siRNA) therapy as a treatment for GA-1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Alice and Y. T. Chen Center for Genetics and Genomics, Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA.
- Department of Biomedical Engineering (BME), Duke University Pratt School of Engineering, Durham, NC 27710, USA.
- Biochemical Genetics Laboratory, Duke University Medical Center, Durham, NC 27710, USA.
- Alnylam Pharmaceuticals, Cambridge, MA 02142, USA.
- Biochemical Genetics Laboratory, Children's Hospital Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
- Division of Gastroenterology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
ORCID-Profile: Yunhan Ma, Maiya Fujiwara, Natasha Murugan, Haoyue Zhang, Sabrina Belozerova, James Beasley, Cheryl K Peck, Sarah Young, Areeg El-Gharbawy, Mercedes Barzi, Beatrice Bissig-Choisat, Leila Noetzli, Karl-Dimiter Bissig
Förderung
- National Cancer Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- Alnylam Pharmaceuticals
Zitieren
APA
Ma, Y., Fujiwara, M., Murugan, N., Zhang, H., Belozerova, S., Beasley, J., Peck, C. K., Wood, T. C., Stiles, A. R., Young, S., El-Gharbawy, A., Barzi, M., Bissig-Choisat, B., Noetzli, L., & Bissig, K. D. (2026). Rescue of glutaric aciduria type I by GalNAc-conjugated siRNA against aminoadipate semialdehyde synthase. Science Translational Medicine, 18(876). https://doi.org/10.1126/scitranslmed.aej2067
Vancouver
Ma Y, Fujiwara M, Murugan N, Zhang H, Belozerova S, Beasley J, et al. Rescue of glutaric aciduria type I by GalNAc-conjugated siRNA against aminoadipate semialdehyde synthase. Science Translational Medicine. 2026;18(876). doi:10.1126/scitranslmed.aej2067
BibTeX
@article{Ma2026,
author = {Ma, Yunhan and Fujiwara, Maiya and Murugan, Natasha and Zhang, Haoyue and Belozerova, Sabrina and Beasley, James and Peck, Cheryl K and Wood, Timothy C and Stiles, Ashlee R and Young, Sarah and El-Gharbawy, Areeg and Barzi, Mercedes and Bissig-Choisat, Beatrice and Noetzli, Leila and Bissig, Karl-Dimiter},
title = {Rescue of glutaric aciduria type I by GalNAc-conjugated siRNA against aminoadipate semialdehyde synthase},
journal = {Science Translational Medicine},
year = {2026},
volume = {18},
number = {876},
doi = {10.1126/scitranslmed.aej2067}
}
EUVIMED